Cargando…
isomiRTar: a comprehensive portal of pan-cancer 5′-isomiR targeting
Inaccurate cleavage of pri- and pre-miRNA hairpins by Drosha and Dicer results in the generation of miRNA isoforms known as isomiRs. isomiRs with 5′-end variations (5′-isomiRs) create a new dimension in miRNA research since they have different seed regions and distinct targetomes. We developed isomi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583861/ https://www.ncbi.nlm.nih.gov/pubmed/36275459 http://dx.doi.org/10.7717/peerj.14205 |
_version_ | 1784813161816260608 |
---|---|
author | Nersisyan, Stepan Gorbonos, Aleksandra Makhonin, Alexey Zhiyanov, Anton Shkurnikov, Maxim Tonevitsky, Alexander |
author_facet | Nersisyan, Stepan Gorbonos, Aleksandra Makhonin, Alexey Zhiyanov, Anton Shkurnikov, Maxim Tonevitsky, Alexander |
author_sort | Nersisyan, Stepan |
collection | PubMed |
description | Inaccurate cleavage of pri- and pre-miRNA hairpins by Drosha and Dicer results in the generation of miRNA isoforms known as isomiRs. isomiRs with 5′-end variations (5′-isomiRs) create a new dimension in miRNA research since they have different seed regions and distinct targetomes. We developed isomiRTar (https://isomirtar.hse.ru)—a comprehensive portal that allows one to analyze expression profiles and targeting activity of 5′-isomiRs in cancer. Using the Cancer Genome Atlas sequencing data, we compiled the list of 1022 5′-isomiRs expressed in 9282 tumor samples across 31 cancer types. Sequences of these isomiRs were used to predict target genes with miRDB and TargetScan. The putative interactions were then subjected to the co-expression analysis in each cancer type to identify isomiR-target pairs supported by significant negative correlations. Downstream analysis of the data deposited in isomiRTar revealed both cancer-specific and cancer-conserved 5′-isomiR expression landscapes. Pairs of isomiRs differing in one nucleotide shift from 5′-end had poorly overlapping targetomes with the median Jaccard index of 0.06. The analysis of colorectal cancer 5′-isomiR-mediated regulatory networks revealed promising candidate tumor suppressor isomiRs: hsa-miR-203a-3p—+1, hsa-miR-192-5p—+1 and hsa-miR-148a-3p—0. In summary, we believe that isomiRTar will help researchers find novel mechanisms of isomiR-mediated gene silencing in different types of cancer. |
format | Online Article Text |
id | pubmed-9583861 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | PeerJ Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95838612022-10-21 isomiRTar: a comprehensive portal of pan-cancer 5′-isomiR targeting Nersisyan, Stepan Gorbonos, Aleksandra Makhonin, Alexey Zhiyanov, Anton Shkurnikov, Maxim Tonevitsky, Alexander PeerJ Bioinformatics Inaccurate cleavage of pri- and pre-miRNA hairpins by Drosha and Dicer results in the generation of miRNA isoforms known as isomiRs. isomiRs with 5′-end variations (5′-isomiRs) create a new dimension in miRNA research since they have different seed regions and distinct targetomes. We developed isomiRTar (https://isomirtar.hse.ru)—a comprehensive portal that allows one to analyze expression profiles and targeting activity of 5′-isomiRs in cancer. Using the Cancer Genome Atlas sequencing data, we compiled the list of 1022 5′-isomiRs expressed in 9282 tumor samples across 31 cancer types. Sequences of these isomiRs were used to predict target genes with miRDB and TargetScan. The putative interactions were then subjected to the co-expression analysis in each cancer type to identify isomiR-target pairs supported by significant negative correlations. Downstream analysis of the data deposited in isomiRTar revealed both cancer-specific and cancer-conserved 5′-isomiR expression landscapes. Pairs of isomiRs differing in one nucleotide shift from 5′-end had poorly overlapping targetomes with the median Jaccard index of 0.06. The analysis of colorectal cancer 5′-isomiR-mediated regulatory networks revealed promising candidate tumor suppressor isomiRs: hsa-miR-203a-3p—+1, hsa-miR-192-5p—+1 and hsa-miR-148a-3p—0. In summary, we believe that isomiRTar will help researchers find novel mechanisms of isomiR-mediated gene silencing in different types of cancer. PeerJ Inc. 2022-10-17 /pmc/articles/PMC9583861/ /pubmed/36275459 http://dx.doi.org/10.7717/peerj.14205 Text en ©2022 Nersisyan et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited. |
spellingShingle | Bioinformatics Nersisyan, Stepan Gorbonos, Aleksandra Makhonin, Alexey Zhiyanov, Anton Shkurnikov, Maxim Tonevitsky, Alexander isomiRTar: a comprehensive portal of pan-cancer 5′-isomiR targeting |
title | isomiRTar: a comprehensive portal of pan-cancer 5′-isomiR targeting |
title_full | isomiRTar: a comprehensive portal of pan-cancer 5′-isomiR targeting |
title_fullStr | isomiRTar: a comprehensive portal of pan-cancer 5′-isomiR targeting |
title_full_unstemmed | isomiRTar: a comprehensive portal of pan-cancer 5′-isomiR targeting |
title_short | isomiRTar: a comprehensive portal of pan-cancer 5′-isomiR targeting |
title_sort | isomirtar: a comprehensive portal of pan-cancer 5′-isomir targeting |
topic | Bioinformatics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583861/ https://www.ncbi.nlm.nih.gov/pubmed/36275459 http://dx.doi.org/10.7717/peerj.14205 |
work_keys_str_mv | AT nersisyanstepan isomirtaracomprehensiveportalofpancancer5isomirtargeting AT gorbonosaleksandra isomirtaracomprehensiveportalofpancancer5isomirtargeting AT makhoninalexey isomirtaracomprehensiveportalofpancancer5isomirtargeting AT zhiyanovanton isomirtaracomprehensiveportalofpancancer5isomirtargeting AT shkurnikovmaxim isomirtaracomprehensiveportalofpancancer5isomirtargeting AT tonevitskyalexander isomirtaracomprehensiveportalofpancancer5isomirtargeting |